It is a high-tech enterprise dedicated to the injection filling between the deep dermis and the superficial subcutaneous layer of the skin, specializing in the research and development/production/sales of biodegradable materials and medical biomaterials

After 7 years, the R&D team composed of postdoctoral fellows from China, the United States, France and Japan has successfully developed and launched the products of Bonita;

In October 2012, Bonida was approved by the State Food and Drug Administration (SFDA) for injection fillers between the deep dermis and the superficial subcutaneous layer of the skin.

Bonida not only plays a filling role, but also maintains the elasticity of the skin, and also locks in a large number of water molecules, making the skin plump, youthful and elastic. The active ingredient of Bonida stimulates the skin's own production of new collagen, which plays a role in long-term filling of wrinkles and depressions.